Editorials

In search of the optimal proteosome inhibitor. How, when and for whom?

University of Freiburg, Hematology and Oncology, Faculty of Freiburg, Hugstetterstr. 53, 79106 Freiburg
Myeloma Unit, Division of Hematology, University of Turino, Azienda Ospedaliero-Universitaria Citta della Salute e della Scienza di Torino, Torino
University Hospital of Nantes, Nantes
University of Freiburg, Hematology and Oncology, Faculty of Freiburg, Hugstetterstr. 53, 79106 Freiburg
University of Freiburg, Hematology and Oncology, Faculty of Freiburg, Hugstetterstr. 53, 79106 Freiburg
Haematologica Early view Apr 29, 2021 https://doi.org/10.3324/haematol.2021.278838